Data-driven Drug Pricing: Technology Solutions that could Change the Paradigm

Jul 22, 2016

With the global pharmaceutical industry expected to be worth £800bn by 2020, the pressure is on to improve efficiency and decision-making in drug research. New drug pipelines are dwindling and the cost of failure is high. The estimated cost of taking a single drug to market is $350 million, and with regulatory agencies demanding more, larger and longer studies due to the increased desire for niche therapies, this figure is only going to increase further. Elliott Frodsham, Business Development and Operations Assistant at Datatrial, shares his thoughts on datadriven drug pricing. ...

Read More

The Future is Bright for BYOD but is it Always the Best Approach?

Jul 22, 2016

Technology is well and truly embedded within the lives of people of all ages, geographic locations and economic backgrounds, ultimately driven by the increasing sophistication and associated reduction in cost of using emerging technology for all kinds of applications. In line with this, the ownership and use of smartphones has become extensive – in fact, it is estimated that by the end of 2016, the number of smartphone users worldwide will exceed two billion. With increasingly tech-savvy consumers, the pharmaceutical industry has reached a point when it can finally begin to consider utilising the low-friction, rich, real-time data that can ...

Read More